Minerva

Minerva

BMJ 2009; 338 doi: http://dx.doi.org/10.1136/bmj.b1405 (Published 08 April 2009) Cite this as: BMJ 2009;338:b1405

Proton pump inhibitors interfere with clopidogrel: a study of patients who received clopidogrel after a first myocardial infarction, including 734 cases who were readmitted with a second myocardial infarction and 2057 controls, found that patients who received concomitant treatment with proton pump inhibitors other than pantoprazole were at increased risk of reinfarction (adjusted odds ratio 1.27, 95% confidence interval 1.03 to 1.57; CMAJ 2009;180:713-8 doi:10.1503/cmaj.082001).

Clever eye tracking devices have enabled researchers in the United States to watch consumers as they read the statements on over-the-counter medications. Despite a requirement from the Food and Drug Administration that certain warnings be made “prominent” and “conspicuous”, it seems that consumers spend the least time looking at the tamper-prevention and child-resistant statements, and the longest time looking at the brand names. And asked what they recalled afterwards, people remembered more information about the brand name than about any warnings on the products they’d looked at (Proceedings of the National Academy of Sciences 2009; published online 30 March, doi:10.1073/pnas.0810665106).

Death due to excessive adiposity is no better predicted from waist measurements than from weight measurements, an editorial …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe